. 2016 Nov 10;11(11):e0166036. doi: 10.1371/journal.pone.0166036

Table 2. Serum 25(OH)D concentrations (ng/mL) by early virologic response (≥ 2-log₁₀ decline in HCV RNA level from baseline to week 12).

Study	Race	Early virologic response				P^*
		Yes		No
		n	Median (IQR)	n	Median (IQR)
HALT-C ^†	European Americans	373	21.9 (16.7–27.4)	341	23.0 (16.2–30.0)	0.261
HALT-C ^†	African Americans	48	12.5 (8.9–17.1)	111	11.5 (8.4–16.4)	0.456
VIRAHEP-C ‡	European Americans	126	27.0 (21.1–34.4)	71	25.9 (18.8–36.2)	0.696
VIRAHEP-C ‡	African Americans	76	13.7 (11.0–21.1)	108	15.1 (10.7–20.1)	0.370

* P-value for Brown-Mood test, two-sided normal approximation

† n = 38 HALT-C participants did not have HCV RNA levels measured at a week 12 and were thus excluded from the EVR analysis

Abbreviations: 25(OH)D, 25-hydroxyvitamin D; HCV, hepatitis C virus; IQR, interquartile range

Table 2. Serum 25(OH)D concentrations (ng/mL) by early virologic response (≥ 2-log10 decline in HCV RNA level from baseline to week 12).